828
Participants
Start Date
August 9, 2010
Primary Completion Date
October 30, 2014
Study Completion Date
October 30, 2014
Everolimus
Early CNI to everolimus conversion
Prograf or Neoral
Active CNI-based control (Prograf or Neoral)
Novartis Investigative Site, Riga
Novartis Investigative Site, Vienna
Novartis Investigative Site, Camperdown
Novartis Investigative Site, Leuven
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Clayton
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Mexico City
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Aguascalientes
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Torreón
Novartis Investigative Site, Málaga
Novartis Investigative Site, Brest
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Fatih / Istanbul
Novartis Investigative Site, Hannover Muenden
Novartis Investigative Site, Büyükçekmece / Ýstanbul
Novartis Investigative Site, Padua
Novartis Investigative Site, Tours
Novartis Investigative Site, Santander
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Bologna
Novartis Investigative Site, Essen
Novartis Investigative Site, Münster
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Tartu
Novartis Investigative Site, Aachen
Novartis Investigative Site, Siena
Novartis Investigative Site, Vandœuvre-lès-Nancy
Novartis Investigative Site, Frankfurt am Main
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Veracruz
Novartis Investigative Site, New Delhi
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, S.-Petersburg
Novartis Investigative Site, Lucknow
Novartis Investigative Site, Krasnodar
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Volzhskiy
Novartis Investigative Site, Samara
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, Novosibirsk
Novartis Investigative Site, CABA
Novartis Investigative Site, San Martín
Novartis Investigative Site, Resistencia
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Linz
Novartis Investigative Site, Linz
Novartis Investigative Site, Nice
Novartis Investigative Site, Pátrai
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Visakhapatnam
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Roma
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Groningen
Novartis Investigative Site, Leiden
Novartis Investigative Site, Oslo
Novartis Investigative Site, Carnaxide - Linda-A-Velha
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Antalya
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY